Company page

In8bio, Inc.

In8bio, Inc. is a public company traded under the ticker INAB on the American market. The company has a market capitalization of approximately $14.08 million. In8bio focuses on developing innovative therapies for cancer treatment, leveraging advanced technologies in the biopharmaceutical sector.